Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
In-hospital delirium increases risk for functional disability, cognitive impairment
Jul 11, 2024
The findings were seen among older adults in the six months following a COVID-19 hospitalization.
Self-administered gerocognitive exam improves detection of cognitive issues in primary care
Jul 02, 2024
Detection rates appear to increase during nonacute office visits.
Vigorous physical activity may preserve cognitive function in high-risk HTN
Jun 24, 2024
High versus low vigorous physical activity was linked to a lower risk of mild cognitive impairment, probable dementia and MCI/probable dementia in a multivariate model.
Cognitive impairment delayed with genetic variant
Jun 20, 2024
The onset of cognitive impairment was delayed among those heterozygous for the apolipoprotein E3 Christchurch variant.
Lifestyle intervention can improve cognition, function in early Alzheimer’s disease
Jun 13, 2024
A significant correlation was seen between lifestyle and both cognitive function and Aβ42/40 ratio.
The 5-Cog paradigm improves diagnosis, management of dementia
Jun 11, 2024
A threefold improvement was seen in dementia care actions with the 5-Cog paradigm, a culturally adept cognitive detection tool.
Simple cognitive test and EMR tool boost dementia care actions in primary care setting, trial finds
By
Kristen Fischer
Jun 07, 2024
A five-minute cognitive assessment test and an electronic medical record (EMR) decision-making add-on system improved dementia diagnosis and care, according to a clinical trial.
Inconsistent state regulations, staff training produce wide variations among states’ antipsychotic...
By
Kimberly Bonvissuto
Feb 28, 2023
Researchers are calling for a closer look at the use of antipsychotics among assisted living residents with dementia after a study found wide variations in prescribing patterns.